Spok Holdings, Inc. (NASDAQ: SPOK), a provider of healthcare communications, has announced that, effective immediately, it has appointed Christine M. Cournoyer, who most recently served as the Chairperson and Chief Executive Officer of N-of-One, Inc., to its board of directors, the company said.
Cournoyer led the transformation of N-of-One from a patient concierge business to a molecular decision support company selling to large health providers and molecular diagnostic commercial labs. She, along with the efforts of the team, created a HIPAA compliant platform running in the cloud that scaled to interpret hundreds of thousands of molecular diagnostics tests.
Cournoyer led a strategic process for N-of-One, resulting in a successful sale to QIAGEN N.V. (NYSE: QGEN; Frankfurt Stock Exchange: QIA), a Netherlands-based provider of Sample to Insight solutions, in 2019. Cournoyer is presently a strategic advisor to digital health companies and is on the board of directors of CareDx, Inc. (NASDAQ: CDNA), a precision medicine company providing solutions for transplant patients.
Cournoyer has operated in publicly traded companies as well as private, venture-backed companies, moving successfully across industries with software as the common thread.
The company also announced that Samme Thompson will be stepping down from the board of directors at Spok´s annual meeting later this year and will not stand for re-election. Thompson became a director of Spok in 2004 and is a member of the Compensation Committee and is Chairman of the Nominating and Governance Committee.
Spok, Inc., a wholly owned subsidiary of Spok Holdings, Inc. (NASDAQ: SPOK), headquartered in Springfield, Virginia, is proud to be a provider of healthcare communications. For more information, visit spok.com or follow @spoktweets on Twitter.
Related Articles